Hyperlipidemia patients carrying LDLR splicing mutation c.1187-2A>G respond favorably to rosuvastatin and PCSK9 inhibitor evolocumab
Release time:2023-03-18Hits:
-
Journal:
Mol Genet Genomics
-
Volume:
297
-
Issue:
3
-
Page Number:
833-841
-
Date of Publication:
2022-05-01